- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of therapeutic targets in management of dementia
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 152, Issue -, Pages 113168
Publisher
Elsevier BV
Online
2022-06-12
DOI
10.1016/j.biopha.2022.113168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
- (2020) Luke Cassidy et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Role of tau protein in Alzheimer's disease: The prime pathological player
- (2020) Shibi Muralidar et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- The Involvement of Metals in Alzheimer’s Disease Through Epigenetic Mechanisms
- (2020) Menghua Cai et al. Frontiers in Genetics
- Metal Toxicity Links to Alzheimer’s Disease and Neuroinflammation
- (2019) Tee Jong Huat et al. JOURNAL OF MOLECULAR BIOLOGY
- New treatment modalities in Alzheimer's disease
- (2019) Emel Koseoglu World Journal of Clinical Cases
- Therapeutic perspective on vascular cognitive impairment
- (2019) Kensuke Toyama et al. PHARMACOLOGICAL RESEARCH
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study
- (2018) Olivia A. Skrobot et al. Alzheimers & Dementia
- White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging
- (2018) Freddy J. Alfaro et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: A focus on human studies
- (2018) Francesca Pistollato et al. PHARMACOLOGICAL RESEARCH
- Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
- (2018) C. Cheignon et al. Redox Biology
- Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments
- (2018) Eric M. Reiman et al. JOURNAL OF ALZHEIMERS DISEASE
- Physical Activity Reduces the Risk of Dementia in Mild Cognitive Impairment Subjects: A Cohort Study
- (2018) Giulia Grande et al. JOURNAL OF ALZHEIMERS DISEASE
- High Manganese, A Risk for Alzheimer's Disease: High Manganese Induces Amyloid-β Related Cognitive Impairment
- (2018) Yawei Tong et al. JOURNAL OF ALZHEIMERS DISEASE
- Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
- (2018) Chen-Chen Tan et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis
- (2018) Balwinder Singh et al. JOURNAL OF ALZHEIMERS DISEASE
- Vitamin D and the Risk of Dementia: The Rotterdam Study
- (2017) Silvan Licher et al. JOURNAL OF ALZHEIMERS DISEASE
- Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage
- (2017) Li Xiong et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway
- (2017) Jingkao Chen et al. JOURNAL OF NEUROIMMUNOLOGY
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2017) Jeff Sevigny et al. NATURE
- Microglia emerge as central players in brain disease
- (2017) Michael W Salter et al. NATURE MEDICINE
- Tau-based therapies in neurodegeneration: opportunities and challenges
- (2017) Chuanzhou Li et al. NATURE REVIEWS DRUG DISCOVERY
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
- (2017) Jun Wang et al. Nature Reviews Neurology
- Early-Onset Alzheimer Disease
- (2017) Mario F. Mendez NEUROLOGIC CLINICS
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us
- (2017) Hélène E. Hirbec et al. Frontiers in Aging Neuroscience
- Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants
- (2016) G. Lopez et al. ACTA NEUROLOGICA SCANDINAVICA
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- New insights on the role of microglia in synaptic pruning in health and disease
- (2016) Soyon Hong et al. CURRENT OPINION IN NEUROBIOLOGY
- Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: A general review of metal mixture mechanism in brain
- (2016) Venkatanaidu Karri et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
- (2016) Serge Gauthier et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease
- (2016) Kuti Baruch et al. NATURE MEDICINE
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- Drug development in Alzheimer’s disease: the path to 2025
- (2016) Jeffrey Cummings et al. Alzheimers Research & Therapy
- A Clinical Approach to the Diagnosis of Traumatic Encephalopathy Syndrome
- (2016) Nicole Reams et al. JAMA Neurology
- Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
- (2016) Mark Ultsch et al. Scientific Reports
- Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
- (2015) Yvonne Bouter et al. ACTA NEUROPATHOLOGICA
- Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective
- (2015) Matthew Baumgart et al. Alzheimers & Dementia
- Toxicant Exposure and Bioaccumulation: A Common and Potentially Reversible Cause of Cognitive Dysfunction and Dementia
- (2015) Stephen J. Genuis et al. BEHAVIOURAL NEUROLOGY
- Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
- (2015) Stephanie J. B. Vos et al. BRAIN
- Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: Systematic review and meta-analysis
- (2015) Vasiliki Orgeta et al. BRITISH JOURNAL OF PSYCHIATRY
- EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
- (2015) R. Schmidt et al. EUROPEAN JOURNAL OF NEUROLOGY
- Motor neuron disease-frontotemporal dementia: a clinical continuum
- (2015) Emma Devenney et al. Expert Review of Neurotherapeutics
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- (2015) Robert Howard et al. LANCET NEUROLOGY
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice
- (2015) Meaghan Morris et al. NATURE NEUROSCIENCE
- Solanezumab—prospects for meaningful interventions in AD?
- (2015) Sam Gandy et al. Nature Reviews Neurology
- Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes
- (2015) Willa D. Brenowitz et al. NEUROBIOLOGY OF AGING
- Multiple-System Atrophy
- (2015) Alessandra Fanciulli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Parathyroid Hormone, Cognitive Function and Dementia: A Systematic Review
- (2015) Ilianna Lourida et al. PLoS One
- Lung disease as a determinant of cognitive decline and dementia
- (2015) James W Dodd Alzheimers Research & Therapy
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults
- (2015) Paula T. Trzepacz et al. BMC Geriatrics
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- Motor neuron disease-frontotemporal dementia: a clinical continuum
- (2015) Emma Devenney et al. Expert Review of Neurotherapeutics
- Potential drug–drug interactions in Alzheimer patients with behavioral symptoms
- (2015) Fabio Monzani et al. Clinical Interventions in Aging
- Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers
- (2015) Guochao Zhong et al. PLoS One
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials
- (2014) Gill Livingston et al. BRITISH JOURNAL OF PSYCHIATRY
- Targeting microglia for the treatment of Alzheimer’s disease
- (2014) Patrick L McGeer et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Diagnosis and Management of Mild Cognitive Impairment
- (2014) Kenneth M. Langa et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Conditions with Neuropsychiatric Manifestations
- (2014) Margaret L. Isaac et al. MEDICAL CLINICS OF NORTH AMERICA
- Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group
- (2014) Iva Stankovic et al. MOVEMENT DISORDERS
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?
- (2014) Torbjörn Persson et al. Oxidative Medicine and Cellular Longevity
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- Frontotemporal Lobar Degeneration: A Clinical Approach
- (2014) Elissaios Karageorgiou et al. SEMINARS IN NEUROLOGY
- The global prevalence of dementia: A systematic review and metaanalysis
- (2013) Martin Prince et al. Alzheimers & Dementia
- Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia
- (2013) Shoaib Afzal et al. Alzheimers & Dementia
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
- (2013) Bin Zhang et al. CELL
- Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease
- (2013) Aaron H. Burstein et al. CLINICAL NEUROPHARMACOLOGY
- Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
- (2013) Jaren W. Landen et al. CLINICAL NEUROPHARMACOLOGY
- Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?
- (2013) J. Teixeira et al. CURRENT MEDICINAL CHEMISTRY
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- α-Synucleinopathy phenotypes
- (2013) Heather McCann et al. PARKINSONISM & RELATED DISORDERS
- Synaptic plasticity in health and disease: introduction and overview
- (2013) T. V. P. Bliss et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
- (2013) S.M. Mills et al. REVUE NEUROLOGIQUE
- Subacute thyroiditis presenting as acute psychosis: a case report and literature review
- (2013) Kyung Ae Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Midlife Blood Pressure, Plasma β-Amyloid, and the Risk for Alzheimer Disease
- (2012) Nilay S. Shah et al. HYPERTENSION
- The clinical features of pathologically confirmed vascular Parkinsonism
- (2012) Philip George Glass et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spectrum of Transient Focal Neurological Episodes in Cerebral Amyloid Angiopathy
- (2012) Andreas Charidimou et al. STROKE
- Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease
- (2011) Qin Nie et al. ACTA PHARMACOLOGICA SINICA
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Structural Basis of C-terminal β-Amyloid Peptide Binding by the Antibody Ponezumab for the Treatment of Alzheimer's Disease
- (2011) Sherry L. La Porte et al. JOURNAL OF MOLECULAR BIOLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease
- (2011) Marina Saresella et al. NEUROBIOLOGY OF AGING
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Vascular risk factors and longitudinal changes on brain MRI: The ARIC study
- (2011) D. S. Knopman et al. NEUROLOGY
- Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
- (2011) R. C. Paolicelli et al. SCIENCE
- Vascular Contributions to Cognitive Impairment and Dementia
- (2011) Philip B. Gorelick et al. STROKE
- Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies
- (2010) Sandi Culo et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions
- (2010) David W. Klaver et al. BIOLOGICAL CHEMISTRY
- Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia
- (2010) Elliott P. Vichinsky JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A PHASE 2 MULTIPLE ASCENDING DOSE TRIAL OF BAPINEUZUMAB IN MILD TO MODERATE ALZHEIMER DISEASE
- (2010) D. T. Laskowitz et al. NEUROLOGY
- Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses
- (2009) Efrat Abramov et al. NATURE NEUROSCIENCE
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Cognitive Impairment in the Aging Dialysis and Chronic Kidney Disease Populations: An Occult Burden
- (2008) Anne M. Murray ADVANCES IN CHRONIC KIDNEY DISEASE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Second consensus statement on the diagnosis of multiple system atrophy
- (2008) S. Gilman et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started